Carpal tunnel syndrome. Carpal tunnel syndrome
Conditions
Interventions
Intervention 1: Intervention group: ozon injection under the ultrasound-guid around the median nerve which will be done by an experienced physical medicine and rehabilitation specialist. Intervention
Treatment - Drugs
Intervention group: ozon injection under the ultrasound-guid around the median nerve which will be done by an experienced physical medicine and rehabilitation specialist
Control group: corticosteroid injection under the ultrasound-guid around the median nerve which will be done by an experienced physical medicine and rehabilitation specialist
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: patients with signs and symptoms of carpal tunnel syndrome (including pain and sensory disturbances in the territory of median nerve) which is confirmed through EMG-NCS and by electrodiagnostic criteria are mild to moderate carpal tunnel syndromes.
Exclusion criteria
Exclusion criteria: severe carpal tunnel syndrome in EMG-NCV tenar atrophy contraindications for corticosteroid injection (including sensitivity to corticosteroids and symptoms of skin infection at the injection site) diseases which mimic CTS symptoms such as polyneuropathy, cervical radiculopathy, thoracic outlet syndrome; surgery or local injection treatments in last six months; neoplastic or traumatic source of pain; wrist bones fracture.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The severity of symptoms and functional limitations. Timepoint: Zero, six and twelve weeks after. Method of measurement: By using Boston questionnare.;The severity of symptoms. Timepoint: Zero, six and twelve weeks after. Method of measurement: Visual Analog Scale(VAS).;Electrodiagnostic criteria. Timepoint: Zero, six and twelve weeks after. Method of measurement: By using EMG-NCV device.;Sonographic criteria. Timepoint: Zero, six and twelve weeks after. Method of measurement: By using Sonographic device. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: Six and twelve weeks after. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contacthosein mohamadi
Iran University of Medical Sciences
Outcome results
None listed